Nargiz Imamova

Dependable professional skilled in time management and multitasking. Proven ability to learn quickly and adapt to new technologies, contributing effectively in both independent and team environments.

Certificate of Animal Use in Experimental Research

Publications

1.Kocazeybek, B., Dinc, H. O., Ergin, S., Saribas, S., Ozcabi, B. T., Cizmecigil, U., ... & Yilmaz, H. (2017). Evaluation of Adenovirus-36 (Ad-36) antibody seropositivity and adipokine levels in obese children. Microbial Pathogenesis, 108, 27-31.

2. Kuskucu, M. A., Aygun, G., Karakullukcu, A., Imamova, N., Kucukbasmaci, O., & Midilli, K. (2018). Development of a Rapid Molecular Test Format Based on Isothermal Recombinase Polymerase Amplification Technique and Lateral Flow Method for Detection of [bla. sub. OXA-48]/[bla. sub. OXA-48]'in Saptanmasi Icin Izotermal Rekombinaz Polimeraz Amplifikasyon Teknigi ve Yanal Akim Yontemine Dayali Hizli Bir Molekuler Test Formatinin Gelistirilmesi. KLIMIK Journal, 31(3), 185-190.

3.Yilmaz, S., Yoruk, A., Zemheri, E., Suakar, O., Imamova, N., Canizci, P., & Kuskucu, A. (2018, November). The Relationship Between Lympadenopathy and HIf-1 Alpha Gene Polymorphism in Children. In PEDIATRIC BLOOD & CANCER (Vol. 65, pp. S213-S214). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.

4.Yilmaz, S., Kuskucu, A., Horoz, O. O., Suakar, O., Imamova, N., Gongor, G., & Yildizdas, D. (2019). Polymorphism of hypoxia-inducible factor-1 α gene in pediatric acute respiratory distress syndrome. Journal of Acute Disease, 8(2), 67-71.

5.Yilmaz, S., Yoruk, A., Zemheri, I. E., Kuskucu, A., Suakar, O., Imamova, N., & Canizci, P. (2019). Hypoxia inducible factor-1 alpha (hif-1 alpha) polymorphism in lymphoma and reactive lymphoid hyperplasia. Asian Pacific Journal of Cancer Biology, 4(2), 35-40.

6.Ari, B. C., Mayda Domac, F., Ozgen Kenangil, G., Imamova, N., & Cinar Kuskucu, A. (2019). The effect of ADORA2A gene polymorphism on the dyskinesia of Parkinson's Disease: 410. Movement Disorders, 34, S166.

7.Barati, A., Huseynzade, A., Imamova, N., Shikhaliyeva, I., Keles, S., Alakbarli, J., ... & Allahverdiyev, A. M. (2024). Nanotechnology and malaria: Evaluation of efficacy and toxicity of green nanoparticles and future perspectives. Journal of Vector Borne Diseases, 61(3), 340-356.

8.Keleş, S., Alakbarli, J., Akgül, B., Baghirova, M., Imamova, N., Barati, A., ... & Allahverdiyev, A. (2024). Nanotechnology based drug delivery systems for malaria. International Journal of Pharmaceutics, 666, 124746.

9.Imamova, N., Feteliyeva, A., & Allahverdiyev, A. M. (2025). Identifying new strategies to combat cytomegalovirus by integrating existing and innovative approaches in diagnosis and treatment. Future Virology, 20(10), 379-395.

Poster

Gurcan, N. E., Ozbey, U., Bilgic, M. B., Tecimel, D., Imamova, N., Kuskucu, A., & Bayrak, O. F. (2020, December). Tumorsphere derived chordoma cancer stem cells have low migration and invasion capacities. In EUROPEAN JOURNAL OF HUMAN GENETICS (Vol. 28, No. SUPPL 1, pp. 501-502). CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND: SPRINGERNATURE.

Networks and membersihps

1.Turkish Microbiological Society

2.Turkish Hospital Infections and Control Association